• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches.

作者信息

Hamilton T C, Young R C, Ozols R F

出版信息

Semin Oncol. 1984 Sep;11(3):285-98.

PMID:6385258
Abstract
摘要

相似文献

1
Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches.卵巢癌的实验模型系统：在新治疗方法设计与评估中的应用
Semin Oncol. 1984 Sep;11(3):285-98.
2
Pharmacologic reversal of drug resistance in ovarian cancer.卵巢癌耐药的药理学逆转
Semin Oncol. 1985 Sep;12(3 Suppl 4):7-11.
3
Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in Vivo.体内单次使用美法仑治疗后，人卵巢肿瘤异种移植模型中耐药性迅速发展。
Anticancer Res. 1998 Jul-Aug;18(4C):3021-5.
4
Collateral susceptibility of adriamycin-, melphalan- and cisplatin-resistant human ovarian tumor cells to bleomycin.阿霉素、美法仑和顺铂耐药的人卵巢肿瘤细胞对博来霉素的 collateral 敏感性 。（注：这里“collateral”在医学语境中可能有特定含义，比如“旁系的、间接相关的”等，具体准确意思需结合更多背景知识确定，单纯从字面翻译是这样）
Jpn J Cancer Res. 1986 Sep;77(9):941-5.
5
Cell survival in four ovarian carcinoma xenografts following in vitro exposure to melphalan, cisplatin and cis-diammine-1,1-cyclobutane dicarboxylate platinum II (CBDCA,JM8).体外暴露于美法仑、顺铂和顺二氨-1,1-环丁烷二羧酸铂II（CBDCA，JM8）后四种卵巢癌异种移植瘤中的细胞存活情况。
Cancer Chemother Pharmacol. 1984;13(2):109-13. doi: 10.1007/BF00257125.
6
Treatment of human ovarian tumor xenografts with selenite prevents the melphalan-induced development of drug resistance.用亚硒酸盐治疗人卵巢肿瘤异种移植可预防美法仑诱导的耐药性发展。
Anticancer Res. 1998 Jul-Aug;18(4C):3017-20.
7
Biological aspects of the subrenal capsule assay of importance in the screening of cytostatic agents.在细胞生长抑制剂筛选中具有重要意义的肾包膜下测定法的生物学方面。
Behring Inst Mitt. 1984 May(74):285-90.
8
Effect of five antineoplastic agents on tumor xenografts with different growth rates.五种抗肿瘤药物对不同生长速率肿瘤异种移植瘤的影响。
J Natl Cancer Inst. 1984 Jun;72(6):1335-9.
9
Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts.使用裸鼠异种移植作为临床前药物筛选：已确立的化疗药物对黑色素瘤和卵巢癌异种移植的体内活性。
Cancer Treat Rep. 1987 Mar;71(3):297-304.
10
Titanocendichloride activity in cisplatin and doxorubicin-resistant human ovarian carcinoma cell lines.
Eur J Cancer. 1993;29A(7):1000-2. doi: 10.1016/s0959-8049(05)80210-2.

引用本文的文献

1
Computationally accelerated identification of P-glycoprotein inhibitors.P-糖蛋白抑制剂的计算加速鉴定
PLoS One. 2025 Aug 13;20(8):e0325121. doi: 10.1371/journal.pone.0325121. eCollection 2025.
2
Metabolomic Analysis of Histological Composition Variability of High-Grade Serous Ovarian Cancer Using H HR MAS NMR Spectroscopy.基于高分辨率魔角旋转核磁共振波谱的高级别浆液性卵巢癌组织学成分变异性的代谢组学分析。
Int J Mol Sci. 2024 Oct 10;25(20):10903. doi: 10.3390/ijms252010903.
3
Combination screen in multi-cell type tumor spheroids reveals interaction between aryl hydrocarbon receptor antagonists and E1 ubiquitin-activating enzyme inhibitor.
多细胞类型肿瘤球体的联合筛选揭示了芳香烃受体拮抗剂与 E1 泛素激活酶抑制剂之间的相互作用。
SLAS Discov. 2024 Oct;29(7):100186. doi: 10.1016/j.slasd.2024.100186. Epub 2024 Oct 1.
4
Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer cell lines and isogenic models.卵巢癌细胞系和同基因模型中的细胞内在铂反应以及相关的遗传和基因表达特征。
bioRxiv. 2024 Jul 29:2024.07.26.605381. doi: 10.1101/2024.07.26.605381.
5
DNA Double-Strand Break Repair Inhibitors: YU238259, A12B4C3 and DDRI-18 Overcome the Cisplatin Resistance in Human Ovarian Cancer Cells, but Not under Hypoxia Conditions.DNA双链断裂修复抑制剂：YU238259、A12B4C3和DDRI-18克服人卵巢癌细胞中的顺铂耐药性，但在缺氧条件下无效。
Curr Issues Mol Biol. 2023 Sep 28;45(10):7915-7932. doi: 10.3390/cimb45100500.
6
Fibroblast growth factor signalling influences homologous recombination-mediated DNA damage repair to promote drug resistance in ovarian cancer.成纤维细胞生长因子信号转导影响同源重组介导的 DNA 损伤修复，从而促进卵巢癌的耐药性。
Br J Cancer. 2022 Oct;127(7):1340-1351. doi: 10.1038/s41416-022-01899-z. Epub 2022 Jul 1.
7
NGF/TRKA Promotes ADAM17-Dependent Cleavage of P75 in Ovarian Cells: Elucidating a Pro-Tumoral Mechanism.NGF/TRKA 促进 ADAM17 依赖性裂解卵巢细胞中的 P75：阐明一种促肿瘤机制。
Int J Mol Sci. 2022 Feb 15;23(4):2124. doi: 10.3390/ijms23042124.
8
Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment.基质金属蛋白酶组织抑制因子（TIMPs）和基质金属蛋白酶（MMPs）在卵巢肿瘤、腹水、腹水来源细胞及癌细胞系中的表达：化疗治疗前后的特征性调节反应
Front Oncol. 2022 Jan 3;11:796588. doi: 10.3389/fonc.2021.796588. eCollection 2021.
9
Inhibition of Poly ADP-Ribose Glycohydrolase Sensitizes Ovarian Cancer Cells to Poly ADP-Ribose Polymerase Inhibitors and Platinum Agents.抑制聚ADP-核糖糖苷水解酶可使卵巢癌细胞对聚ADP-核糖聚合酶抑制剂和铂类药物敏感。
Front Oncol. 2021 Oct 27;11:745981. doi: 10.3389/fonc.2021.745981. eCollection 2021.
10
Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells.通过沉默谷氨酰胺合成酶对谷氨酰胺代谢的重编程诱导 A2780 卵巢癌细胞对顺铂耐药。
BMC Cancer. 2021 Feb 17;21(1):174. doi: 10.1186/s12885-021-07879-5.